03/09/2026
In plasma purification, experience isn't just valuable, it's critical.
When manufacturing plasma-derived therapies, changing purification technologies isn't as simple as switching suppliers. Regulatory history, validated performance, and long-term manufacturing support all play an important role in reducing risk and maintaining continuity.
Our latest blog explores why a proven regulatory track record should be a key consideration when selecting purification technologies for plasma fractionation and how decades of experience can help support licensed manufacturing throughout a product's lifecycle.
Read the blog: https://loom.ly/4lMuwiU